Extracellular Vesicles | CHOP Research Institute

Can a Small Molecule Drug Improve Cell Fitness for Transplantation?

Published on

Oct 20, 2023

Snapshot Science: Can a Drug Improve Cells for Transplantation?

Researchers found exposing cells to a small molecule drug improves cell fitness during hematopoietic stem cell transplants, which could improve ex vivo gene therapy.

Comprehensive Bone Marrow Failure Center

The Comprehensive Bone Marrow Failure Center brings together physicians and researchers to provide state-of-the-art diagnostics, clinical care, and investigational studies, as well as basic research focused on acquired and inherited bone marrow failure.

Kurre Laboratory

The Kurre Laboratory has a longstanding interest in Fanconi Anemia (FA), a genetic condition with prominent hematologic complications.

Peter Kurre, MD

Dr. Kurre's laboratory has longstanding expertise in Fanconi Anemia (FA), a genetic condition with prominent hematologic complications. With training in transplantation and hematopoietic stem cell biology, he hopes to improve the understanding of the progressive hematopoietic failure in patients with bone marrow failure and FA, broaden diagnostic approaches, and develop next generation therapies.

E-mail:

kurrep [at] chop.edu